Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Velilla TA, Guijarro C, Ruiz RC, Piñero MR, Francisco Valderrama Marcos J, López AMB, López AM, Antonio García Donaire J, Obaya JC, Castilla Guerra L, Carratalá VP, Cabello IE, Lazo MS, Rodrigo MMC, María Mostaza Prieto J, Doblas JJG, Soto AB; en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular. Velilla TA, et al. Among authors: lazo ms. Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):474-483. doi: 10.1016/j.nefroe.2023.08.002. Epub 2023 Oct 8. Nefrologia (Engl Ed). 2023. PMID: 37813740 Free article.
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?
Arrobas Velilla T, Guijarro C, Ruiz RC, Piñero MR, Valderrama Marcos JF, Pérez Pérez A, Botana López AM, López AM, García Donaire JA, Obaya JC, Castilla-Guerra L, Carratalá VP, Cabello IE, Lazo MS, Castellanos Rodrigo MM, Mostaza Prieto JM, Gómez Doblas JJ, Buño Soto A; Multidisciplinary Task Force for Lipids and Vascular Risk. Arrobas Velilla T, et al. Among authors: lazo ms. Adv Lab Med. 2023 Jun 5;4(2):138-156. doi: 10.1515/almed-2023-0047. eCollection 2023 Jun. Adv Lab Med. 2023. PMID: 38075943 Free PMC article.
[COVID 19 and myoclonus, do hemodialysis patients have more risk?].
Heres SVP, Fosalba NA, Prieto AB, Morales WAA, Lazo MS. Heres SVP, et al. Among authors: lazo ms. Nefrologia. 2021 Dec 7. doi: 10.1016/j.nefro.2021.11.007. Online ahead of print. Nefrologia. 2021. PMID: 34898785 Free PMC article. Spanish.
Xanthogranulomatous Pyelonephritis in Peritoneal Dialysis.
Martín JB, Tejederas MA, García FA, de la Prada Álvarez FJ, Lazo MS. Martín JB, et al. Among authors: lazo ms. Case Rep Nephrol Dial. 2024 Jun 5;14(1):64-69. doi: 10.1159/000536489. eCollection 2024 Jan-Dec. Case Rep Nephrol Dial. 2024. PMID: 39015126 Free PMC article.
Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study.
Siwy J, Keller F, Banasik M, Peters B, Dudoignon E, Mebazaa A, Gülmez D, Spasovski G, Lazo MS, Rajzer MW, Fuławka Ł, Dzitkowska-Zabielska M, Mischak H, Hecking M, Beige J, Wendt R, UriCoV Working Group. Siwy J, et al. Among authors: lazo ms. Biomedicines. 2024 Sep 13;12(9):2090. doi: 10.3390/biomedicines12092090. Biomedicines. 2024. PMID: 39335603 Free PMC article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.
Staessen JA, Wendt R, Yu YL, Kalbitz S, Thijs L, Siwy J, Raad J, Metzger J, Neuhaus B, Papkalla A, von der Leyen H, Mebazaa A, Dudoignon E, Spasovski G, Milenkova M, Canevska-Taneska A, Salgueira Lazo M, Psichogiou M, Rajzer MW, Fuławka Ł, Dzitkowska-Zabielska M, Weiss G, Feldt T, Stegemann M, Normark J, Zoufaly A, Schmiedel S, Seilmaier M, Rumpf B, Banasik M, Krajewska M, Catanese L, Rupprecht HD, Czerwieńska B, Peters B, Nilsson Å, Rothfuss K, Lübbert C, Mischak H, Beige J; CRIT-CoV-U investigators. Staessen JA, et al. Lancet Digit Health. 2022 Oct;4(10):e727-e737. doi: 10.1016/S2589-7500(22)00150-9. Epub 2022 Aug 31. Lancet Digit Health. 2022. PMID: 36057526 Free PMC article.
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
Bushinsky DA, Raggi P, Bover J, Ketteler M, Bellasi A, Rodriguez M, Sinha S, Garg R, Perelló J, Gold A, Chertow GM; CaLIPSO Investigators*; CaLIPSO Study Group and Clinipace GmbH, Intrinsic Imaging, LLC. Bushinsky DA, et al. Clin J Am Soc Nephrol. 2021 May 8;16(5):736-745. doi: 10.2215/CJN.16931020. Epub 2021 Apr 7. Clin J Am Soc Nephrol. 2021. PMID: 33835939 Free PMC article. Clinical Trial.
Management and outcome of mechanically ventilated neurologic patients.
Pelosi P, Ferguson ND, Frutos-Vivar F, Anzueto A, Putensen C, Raymondos K, Apezteguia C, Desmery P, Hurtado J, Abroug F, Elizalde J, Tomicic V, Cakar N, Gonzalez M, Arabi Y, Moreno R, Esteban A; Ventila Study Group. Pelosi P, et al. Crit Care Med. 2011 Jun;39(6):1482-92. doi: 10.1097/CCM.0b013e31821209a8. Crit Care Med. 2011. PMID: 21378554
Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients.
Nin N, Lombardi R, Frutos-Vivar F, Esteban A, Lorente JA, Ferguson ND, Hurtado J, Apezteguia C, Brochard L, Schortgen F, Raymondos K, Tomicic V, Soto L, González M, Nightingale P, Abroug F, Pelosi P, Arabi Y, Moreno R, Anzueto A; VENTILA Group. Nin N, et al. Shock. 2010 Aug;34(2):109-16. doi: 10.1097/SHK.0b013e3181d671a6. Shock. 2010. PMID: 20634655